18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: Adding value to clinical staging

Journal of Nuclear Medicine

Volumn 53, Issue 5, 2012, Pages 709-715

  Dibble, Elizabeth H ^a   Alvarez, Ana C Lara ^a   Truong, Minh Tam ^a   Mercier, Gustavo ^a   Cook, Earl F ^b   Subramaniam, Rathan M ^a,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Metabolic tumor volume; Oral and oropharyngeal SCC; Staging; Total glycolic activity

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOVERSOL; OPTIRAY IV; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONFIDENCE INTERVAL; FEMALE; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; IMAGE RECONSTRUCTION; MALE; MEASUREMENT; METABOLIC TUMOR VOLUME; MOUTH CANCER; MOUTH SQUAMOUS CELL CARCINOMA; ONCOLOGICAL PARAMETERS; OROPHARYNX CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROPORTIONAL HAZARDS MODEL; RELIABILITY; RETROSPECTIVE STUDY; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; STANDARDIZED UPTAKE VALUE; TOTAL GLYCOLYTIC ACTIVITY; GLYCOLYSIS; METABOLISM; MIDDLE AGED; MOUTH TUMOR; MULTIVARIATE ANALYSIS; OROPHARYNX TUMOR; PATHOLOGY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; GLYCOLYSIS; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOPLASMS, SQUAMOUS CELL; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TUMOR BURDEN;

EID: 84860705942     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.099531     Document Type: Article

References (29)

1. American Cancer Society Cancer Statistics 2011. Available at: Www.cancer.org/Research/CancerFactsFigures/index. Accessed March 21, 2012.
2. van der Schroeff MP, Baatenburg de Jong RJ. Staging and prognosis in head and neck cancer. Oral Oncol. 2009;45:356-360.
3. Quon A, Fischbein NJ, McDougall IR, et al. Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma. J Nucl Med. 2007;48(supp l):58S-67S. (Pubitemid 47604943)
4. Subramaniam RM, Truong M, Peller P, Sakai O, Mercier G. Fluorodeoxyglucosepositron-emission tomography imaging of head and neck squamous cell cancer. AJNR. 2010;31:598-604.
5. Davison JM, Ozonoff A, Imsande HM, Grillone GA, Subramaniam RM. Squamous cell carcinoma of the palatine tonsils: FDG standardized uptake value ratio as a biomarker to differentiate tonsillar carcinoma from physiologic uptake. Radiology. 2010;255:578-585.
6. Allal AS, Slosman DO, Kebdani T, Allaoua M, Lehmann W, Dulguerov P. Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys. 2004;59:1295-1300. (Pubitemid 38954050)
7. Liao CT, Wang HM, Huang SF, et al. PET and PET/CT of the neck lymph nodes improves risk prediction in patients with squamous cell carcinoma of the oral cavity. J Nucl Med. 2011;52:180-187.
8. Seol YM, Kwon BR, Song MK, et al. Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemoradiation therapy. Acta Oncol. 2010;49:201-208.
9. Lee P, Weerasuriya DK, Lavori PW, et al. Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys. 2007;69:328-333. (Pubitemid 47380105)
10. Hardiprodjo D, Ryan T, Truong M, Mercier G, Subramaniam R. Parotid gland tumors: Preliminary data for the value of FDG PET/CT diagnostic parameters. AJR. 2012;198:W185-190.
11. Hatt M, Visvikis D, Albarghach NM, Tixier F, Pradier O, Cheze-le Rest C. Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology. Eur J Nucl Med Mol Imaging. 2011;38:1191-1202.
12. Werner-Wasik M, Nelson AD, Choi W, et al. What is the best way to contour lung tumors on PET scans? Multiobserver validation of a gradient-based method using a NSCLC digital PET phantom. Int J Radiat Oncol Biol Phys. 2012;82:1164-1171.
13. Geets X, Lee JA, Bol A, Lonneux M, Gregoire V. A gradient-based method for segmenting FDG-PET images: Methodology and validation. Eur J Nucl Med Mol Imaging. 2007;34:1427-1438. (Pubitemid 47312577)
14. Social Security death index. Ancestry.com Web site. Available at: Http://search. ancestry.com/search/db.aspx?dbid53693. Accessed March 22, 2012.
15. Hofele C, Freier K, Thiele OC, Haberkorn U, Buchmann I. High 2-[18F]fluoro-2-deoxy-d-glucose (18FDG) uptake measured by positron emission tomography is associated with reduced overall survival in patients with oral squamous cell carcinoma. Oral Oncol. 2009;45:963-967.
16. Studer G. Lütolf U, El-Bassiouni M, Rousson V, Glanzmann C. Volumetric staging (VS) is superior to TNM and AJCC staging in predicting outcome of head and neck cancer treated with IMRT. Acta Oncol. 2007;46:386-394. (Pubitemid 46625041)
17. Minn H, Lapela M, Klemi PJ, et al. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med. 2007;38: 1907-1911.
18. Allal A, Dulguerov P, Allaoua M, et al. Standardized uptake value of 2-[18F] fl uoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. J Clin Oncol. 2002;20: 1398-1404. (Pubitemid 34177448)
19. Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: A simulation study. J Nucl Med. 2004;45:1519-1527. (Pubitemid 47618506)
20. Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors. J Nucl Med.2009;50(suppl 1):122S-150S.
21. Jeganathan R, McGuigan J, Campbell F, Lynch T. Does pre-operative estimation of oesophageal tumour metabolic length using 18F-fluorodeoxyglucose PET/CT images compare with surgical pathology length? Eur J Nucl Med Mol Imaging. 2011;38:656-662.
22. Wu X, Dastidar P, Pertovaara H, et al. Early Treatment response evaluation in patients with diffuse large B-cell lymphoma: A pilot study comparing volumetric MRI and PET/CT. Mol Imaging Biol. 2011;13:785-792.
23. Lee P, Bazan JG, Lavori PW, et al. Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer. Clin Lung Cancer. 2012;13:52-58.
24. Murphy JD, Chisholm KM, Daly ME, et al. Correlation between metabolic tumor volume and pathologic tumor volume in squamous cell carcinoma of the oral cavity. Radiother Oncol. 2011;101:356-361.
25. Huang W, Zhou T, Ma L, et al. Standard uptake value and metabolic tumor volume of 18F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2011;38:1628-1635.
26. Schinagl DA, Vogel WV, Hoffmann AL, van Dalen JA, Oyen WJ, Kaanders JH. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;69:1282-1289. (Pubitemid 47625859)
27. Schinagl DA, Span PN, Oyen WJ, Kaanders JH. Can FDG PET predict radiation treatment outcome in head and neck cancer? Results of a prospective study. Eur J Nucl Med Mol Imaging. 2011;38:1449-1458.
28. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24-35.
29. Wang W, Larson SM, Fazzari M, et al. Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. J Clin Endocrinol Metab. 2000;85:1107-1113. (Pubitemid 32269357)